ALLMedicine™ Oral Infections Center
Research & Reviews 199 results
https://clinicaltrials.gov/ct2/show/NCT05720104
Mar 9th, 2023 - The dental condition of elderly care customers is often poor. Cavities and dental connective tissue disease are widespread in people over 75 and older. Untreated oral infections in patients or residents living in institutional care predispose to p...
https://clinicaltrials.gov/ct2/show/NCT05758207
Mar 7th, 2023 - Oral lesions can be the first presentation of hematological malignancy. Dentists occasionally are the first healthcare provider that detect oral signs related to a systemic condition and thus contribute to the early diagnosis of the disease 1. Ora...
https://clinicaltrials.gov/ct2/show/NCT05724043
Feb 13th, 2023 - INTRODUCTION Poor oral health is common in frail and care-dependent older adults and includes tooth loss, poor oral hygiene, high prevalence of dental caries and periodontal disease, defective dental prostheses, hyposalivation and various oral les...
https://clinicaltrials.gov/ct2/show/NCT01568697
Feb 8th, 2023 - This is a cross sectional/natural history protocol designed to investigate the clinical, microbiologic, and immunologic consequences of genetic immune defects in the oral cavity. The hypothesis is that genetic immune defects will lead to alteratio...
https://doi.org/10.1016/j.ijbiomac.2023.123420
International Journal of Biological Macromolecules; Wu Y, Gao H et. al.
Jan 29th, 2023 - Natural isoflavonoids have attracted much attention in the treatment of oral bacterial infections and other diseases due to their excellent antibacterial activity and safety. However, their poor water solubility, instability and low bioavailabilit...
Clinicaltrials.gov 26 results
https://clinicaltrials.gov/ct2/show/NCT05720104
Mar 9th, 2023 - The dental condition of elderly care customers is often poor. Cavities and dental connective tissue disease are widespread in people over 75 and older. Untreated oral infections in patients or residents living in institutional care predispose to p...
https://clinicaltrials.gov/ct2/show/NCT05758207
Mar 7th, 2023 - Oral lesions can be the first presentation of hematological malignancy. Dentists occasionally are the first healthcare provider that detect oral signs related to a systemic condition and thus contribute to the early diagnosis of the disease 1. Ora...
https://clinicaltrials.gov/ct2/show/NCT05724043
Feb 13th, 2023 - INTRODUCTION Poor oral health is common in frail and care-dependent older adults and includes tooth loss, poor oral hygiene, high prevalence of dental caries and periodontal disease, defective dental prostheses, hyposalivation and various oral les...
https://clinicaltrials.gov/ct2/show/NCT01568697
Feb 8th, 2023 - This is a cross sectional/natural history protocol designed to investigate the clinical, microbiologic, and immunologic consequences of genetic immune defects in the oral cavity. The hypothesis is that genetic immune defects will lead to alteratio...
https://clinicaltrials.gov/ct2/show/NCT05654129
Dec 16th, 2022 - Non-alcoholic fatty liver disease is becoming the leading cause of chronic liver disease with a prevalence of 20% worldwide. The prognosis depends on the degree of fibrosis: patients with a low degree of fibrosis (F0-F2) have a good prognosis unli...
News 21 results
https://www.medpagetoday.com/cardiology/arrhythmias/101509
Oct 31st, 2022 - Growing evidence suggests periodontitis as a possible modifiable risk factor for atrial fibrillation (Afib), though left unanswered is the question of whether improving oral health can help clinical outcomes. A histologic association between infla...
https://www.medpagetoday.com/psychiatry/generalpsychiatry/96634
Jan 12th, 2022 - The FDA issued a warning over possible dental problems -- including tooth decay, cavities, oral infections, and loss of teeth -- with orally dissolving medications containing buprenorphine used for the treatment of opioid use disorder and pain. Ho...
https://www.onclive.com/view/2017-asco-annual-meeting-presscast
Apr 2nd, 2021 - Today- Highlights from a presscast held ahead of the 2017 ASCO Annual Meeting. Welcome to OncLive News Network! I’m Gina Columbus. Phase III results showed that adjuvant gefitinib reduced the risk of disease recurrence by 40% versus stand...
https://www.onclive.com/view/hpv-vaccine-reduced-highrisk-oral-infections-by-nearly-90-but-poor-uptake-limits-impact
Dec 20th, 2020 - Maura L. Gillison, MD, PhD The efficacy of the human papillomavirus (HPV) vaccine continues to be impressive, with newly reported findings showing that it reduced the prevalence of high-risk oral HPV infections by 88% in young adults who had at l...
https://www.onclive.com/view/asco-panel-sees-greater-utility-for-bonemodifying-agents-in-myeloma
Dec 5th, 2020 - Kenneth C. Anderson, MD In updated guidelines exploring the role of bone-modifying agents, the American Society of Clinical Oncology (ASCO) has recommended expanding the use of bisphosphonates to include all patients being treated for active mult...